采用 11 倍扩增显微镜的通用分子保留

Executive Industry Relevance

Magnify expansion microscopy enables nanoscale imaging of diverse biological and clinical specimens using standard optical microscopes, eliminating the need for specialized super-resolution equipment. This capability increases predictive confidence in disease mechanism studies and supports translational research by preserving proteins, lipids, and nucleic acids in challenging sample formats. The method addresses a critical inflection point in discovery and pathology pipelines by enabling robust, reproducible molecular visualization across tissue types.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Facilitates interrogation of disease-relevant pathways at the nanoscale in intact tissues.
• Enables functional target validation by preserving multiple biomolecule classes for multiplexed analysis.
• Supports predictive confidence in mechanistic studies by minimizing sample loss and distortion.

Screening & Assay Development

• Prepares validated, highly expanded biological systems for downstream imaging and analysis workflows.
• Standardizes sample preparation and imaging across tissue types, improving reproducibility.
• Delivers quantitative, high-resolution outputs suitable for comparative compound evaluation.

Translational & Preclinical Research

• Aligns nanoscale imaging with clinical sample formats, supporting translational biomarker discovery.
• Enables continuity from discovery through preclinical validation by accommodating formalin-fixed paraffin-embedded tissues.
• Reduces risk in advancing candidates by providing detailed molecular context in disease models.

Pipeline & Workflow Integration

Magnify positions nanoscale imaging within the continuum from early discovery through preclinical research, bridging basic and clinical sample analysis.

• Discovery Biology: Supports hypothesis testing and pathway clarification by enabling visualization of molecular architecture in situ.
• Screening: Provides assay-ready, reproducible expanded samples for high-content imaging and analysis.
• Analytics: Generates quantitative, multiplexed readouts for robust statistical comparison of experimental conditions.
• Translational Research: Maintains biomolecule integrity in clinical formats, facilitating biomarker alignment and disease mechanism studies.
• Enterprise Reuse: Offers a broadly adaptable imaging platform for diverse R&D programs without the need for custom anchoring chemistries.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target and pathway studies.
• Operational Value: Standardizes and simplifies nanoscale imaging workflows, enhancing reproducibility and scalability.
• Strategic Value: Enables better go/no-go decisions by providing high-resolution molecular data from clinically relevant samples.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery and translational programs.

Implementation Considerations

• Requires expertise in tissue handling, gel chemistry, and fluorescence imaging.
• Needs access to standard optical or confocal microscopy and basic laboratory infrastructure.
• Demands cross-team standardization of sample preparation and imaging protocols for reproducibility.
• Adaptable to a wide range of tissue types and sample formats, including archived clinical specimens.
• Limitations include potential for sample cracking or loss if anchoring or homogenization steps are inadequate.

Biopharma FAQs